2018
DOI: 10.1016/j.nano.2018.04.020
|View full text |Cite
|
Sign up to set email alerts
|

Early detection of pancreatic cancers in liquid biopsies by ultrasensitive fluorescence nanobiosensors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
26
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 29 publications
(27 citation statements)
references
References 23 publications
1
26
0
Order By: Relevance
“…It is established that virtually all solid tumors are characterized by dysfunctional protease expression patterns [20][21][22] . These deviations from the proteasome of healthy cells have been successfully used by the authors for the early detection of breast [5] and pancreatic [7] cancer. In cancer, numerous proteases, such as matrix metalloproteinases (MMPs) [23] , cathepsins [24][25][26] , and urokinase plasminogen activator (uPA) [20,22,25] are either over-or underexpressed, when compared to healthy cells.…”
Section: Optical Nanobiosensors For Protease Detectionmentioning
confidence: 99%
See 2 more Smart Citations
“…It is established that virtually all solid tumors are characterized by dysfunctional protease expression patterns [20][21][22] . These deviations from the proteasome of healthy cells have been successfully used by the authors for the early detection of breast [5] and pancreatic [7] cancer. In cancer, numerous proteases, such as matrix metalloproteinases (MMPs) [23] , cathepsins [24][25][26] , and urokinase plasminogen activator (uPA) [20,22,25] are either over-or underexpressed, when compared to healthy cells.…”
Section: Optical Nanobiosensors For Protease Detectionmentioning
confidence: 99%
“…In cancer, numerous proteases, such as matrix metalloproteinases (MMPs) [23] , cathepsins [24][25][26] , and urokinase plasminogen activator (uPA) [20,22,25] are either over-or underexpressed, when compared to healthy cells. This enables the detection of solid tumors in liquid biopsies through the simultaneous detection of several proteases in serum [5,7] . The Bossmann group has continuously developed their patented technology for ultra-sensitive protease detection since 2007 [27][28][29] .…”
Section: Optical Nanobiosensors For Protease Detectionmentioning
confidence: 99%
See 1 more Smart Citation
“…Bossmann and co-workers have developed fluorescence-based nanobiosensors for the detection of solid tumors in liquid biopsies and protease detection in blood [18,22,[76][77][78]. These nanobiosensors feature Fe/Fe 3 O 4 core/shell nanoparticles, which were synthesized by using thermal decomposition of Fe(CO) 5 in the presence of oleylamine and hexadecylammonium chloride (HADxHCl) using 1-octadecene (ODE) as solvent [79].…”
Section: Iron/iron Oxide Core/shell Nanoparticlesmentioning
confidence: 99%
“…Magnetic nanoparticles play a big role in cancer detection [7][8][9], drug delivery [2,3], as well as hyperthermia treatment [10][11][12]. During the last decade, bi-magnetic core/shell nanoparticles featuring an iron core and an iron oxide (Fe 3 O 4 ) shell have become widely used [13][14][15][16][17][18][19], due to their superior magnetic properties [20,21].…”
Section: Introductionmentioning
confidence: 99%